COOLSCULPTING SYSTEM
Report
- Report Number
- 3007215625-2023-12028
- Event Type
- Injury
- Date Received
- August 8, 2023
- Report Date
- November 16, 2023
- Manufacturer
- ALLERGAN (PLEASANTON)
- Product Code
- OOK
- UDI-DI
- 00816417020001
- PMA / PMN Number
- K160259
- Removal / Correction Number
- Z-1347-2022
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- US
- Reporter Occupation
- OTHER
- Health Professional
- N
Narratives
THIS IS A HISTORICAL RECORD AND REFLECTS REPORTS THAT WERE RECEIVED BY THE COMPANY PRIOR TO APRIL 2021. THIS MDR IS ASSOCIATED WITH A PARALLEL PLATE APPLICATOR, THESE APPLICATORS WERE DISCONTINUED AND RECALLED IN 2022. ACCORDING TO THE COOLSCULPTING USER MANUAL, UNDER RARE ADVERSE EVENTS, PARADOXICAL ADIPOSE HYPERPLASIA (PH/PAH) IS CHARACTERIZED BY A VISIBLY ENLARGED TISSUE VOLUME WITHIN THE TREATMENT AREA, WHICH MAY DEVELOP TWO TO FIVE MONTHS AFTER TREATMENT. SURGICAL INTERVENTION MAY BE REQUIRED. PAH IS NOT RELATED TO ANY COOLSCULPTING DEVICE FAILURE MODE BUT IT IS OBSERVED MORE FREQUENTLY WITH THE PARALLEL PLATE APPLICATORS. PAH IS INCLUDED IN THE RISK MANAGEMENT FILES OF THE DEVICE AS AN INHERENT RISK TO THE USE OF CRYOLIPOLYSIS FOR LOCALIZED FAT REDUCTION.
CORRECTED DATA D1 - BRAND NAME.
ALLERGAN AESTHETICS RECEIVED A REPORT OF A MALE PATIENT TREATED WITHCOOLSCULPTING TO THE BILATERAL UPPER AND LOWER ABDOMEN ON (B)(6) 2016 USING COOLCORE APPLICATOR WHO WAS DIAGNOSED WITH PARADOXICAL HYPERPLASIA (PAH/PH) ON (B)(6) 2017 TO THE UPPER AND LOWER ABDOMEN. PAH WAS DESCRIBED AS ENLARGED, DISTORTED, AND FIRM. ON AN UNKNOWN DATE IN (B)(6) 2017 THE PATIENT RECEIVED LIPOSUCTION TO RESOLVE PAH BUT THE FAT CELLS GREW BACK. THE PATIENT WAS ASSESSED WITH PAH PROGRESSION TO THE UPPER AND LOWER ABDOMEN.
ALLERGAN AESTHETICS RECEIVED A REPORT OF A MALE PATIENT TREATED WITHCOOLSCULPTING TO THE BILATERAL UPPER AND LOWER ABDOMEN ON (B)(6) 2016 USING COOLCORE APPLICATOR WHO WAS DIAGNOSED WITH PARADOXICAL HYPERPLASIA (PAH/PH) ON (B)(6) 2017 TO THE UPPER AND LOWER ABDOMEN. PAH WAS DESCRIBED AS ENLARGED, DISTORTED, AND FIRM. ON AN UNKNOWN DATE IN (B)(6) 2017 THE PATIENT RECEIVED LIPOSUCTION TO RESOLVE PAH BUT THE FAT CELLS GREW BACK. THE PATIENT WAS ASSESSED WITH PAH PROGRESSION TO THE UPPER AND LOWER ABDOMEN.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1338060 | COOLSCULPTING SYSTEM | DERMAL COOLING PACK/VACUUM/MASSAGER | OOK | ALLERGAN (PLEASANTON) | NI | 00816417020001 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 33 YR | Male | Required Intervention | (B)(6) |